Current Alzheimer Research

Papers
(The TQCC of Current Alzheimer Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Serine Racemase Expression Differentiates Aging from Alzheimer’s Brain25
Construction of lncRNA-ceRNA Networks to Reveal the Potential Role of Lfng/Notch1 Signaling Pathway in Alzheimer’s Disease25
Early Memory Impairment is Accompanied by Changes in GluA1/ p-GluA1 in APP/PS1 Mice22
Associations between Physical Performance Tests with Cognitive Changes: The Moderating Effect of Cognitive Status19
Role of GSK-3 Inhibition in Alzheimer’s Disease Therapy19
Microglia PTK2B/Pyk2 in the Pathogenesis of Alzheimer’s Disease19
Recent Updates on Alzheimer’s Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease19
Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases18
Anthocyanidins Intake is Associated with Alzheimer’s Disease Risk in Americans over 60 Years of Age: Data from NHANES 2007-2008, 2009-2010, and 2017-201818
Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial18
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease16
Effects of the Recurrent and Different Doses of Ketamine Exposure on Anxiety-like Behaviors and Locomotor Activity in Juvenile Rats15
Advances in Nose-to-Brain Delivery Systems for Effective Alzheimer's Disease Management15
The Cause-and-Consequence Relationships between Domestic Abuse and Alzheimer’s Disease: Identification of Five Subtypes15
Blood Neurofilament Light Chain in Different Types of Dementia14
Development and Psychometric Validation of the 27 Item Zarit Caregiver Interview for Alzheimer’s Disease (ZCI-AD-27)14
Trafficking of Muscarinic 1 Acetylcholine Receptor Regulated by VPS35 in Alzheimer's Disease13
The Framework for an Integrative Theory of Alzheimer’s Disease13
Acknowledgements to Reviewers13
Artificial Intelligence in Eye Movements Analysis for Alzheimer’s Disease Early Diagnosis12
Improving Quality of Life in Dementia through Tailored Interventions: A Systematic Review from Saudi Arabia11
Glial-derived Neuroinflammation induced with Amyloid-beta-peptide Plus Fibrinogen Injection in Rat Hippocampus11
Imagine Yourself Dancing Waltz: The Effect of Imagination on Memory in Alzheimer’s Disease11
Retraction Notice: Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice11
Multifunctional Tasks and an Energy Crisis are Crucial Players in Determining the Vulnerability of the Entorhinal Cortex to Early Damage in Alzheimer’s Disease11
The Association of Allergy-Related and Non-Allergy-Related Olfactory Impairment with Cognitive Function in Older Adults: Two Cross- Sectional Studies11
Acupuncture Improves Synaptic Plasticity of SAMP8 Mice through the RhoA/ROCK Pathway10
Influence of Inflammation, Gut Microbiota, and Stress on Cognition and Oral Health Therapies10
Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 202010
Roles of Microglia in AD Pathology10
Associations between Handwriting Decline and Cognitive-Motor Impairment in Dementia10
Radio-Anatomical Assessment of Cerebellum Volume in Individuals with Alzheimer's Disease9
Mapping the Connection Between Circadian Rhythms, Metabolism, and Neurodegeneration: Exploring Therapeutic Strategies9
Vascular Lesions and Brain Atrophy in Alzheimer’s, Vascular and Mixed Dementia: An Optimized 3T MRI Protocol Reveals Distinctive Radiological Profiles9
The Association between the rs6656401 Locus of the CR1 Gene and Structural Alterations of Brain Effects in Han Chinese Patients with Alzheimer's Disease8
The Importance of Long-term Partner Observation in Cognitive Evaluation: A Very Early Creutzfeldt-Jakob Disease in a Patient with Mild Cognitive Impairment8
Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats8
Proposed Therapeutic Strategy to Combat Alzheimer’s Disease by Targeting Beta and Gamma Secretases8
Landmark Model-based Individual Dynamic Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease using Cognitive Screening8
Pharmacological Attributes of Fenugreek with Special Reference to Alzheimer’s Disease8
Associations Between Metabolomics Findings and Brain Hypometabolism in Mild Cognitive Impairment and Alzheimer’s Disease8
Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue8
Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum7
Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration7
Climate Change and Global Warming: Are Individuals with Dementia - Including Alzheimer’s Disease - At a Higher Risk?7
Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis7
Common Neuropsychiatric Symptoms in Alzheimer’s Disease, Mild Cognitive Impairment, and Subjective Memory Complaints: A Unified Framework7
Research Progress of Mitophagy in Alzheimer's Disease7
Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study7
Decoding microRNA-Protein Interaction Networks in Alzheimer’s Disease: Molecular Mechanisms and Clinical Implications7
Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features6
Research Progress of Eye Movement Analyses and its Detection Algorithms in Alzheimer’s Disease6
Research Progress on the Pathogenesis, Therapeutic Strategies, andPhthalocyanine Compounds for Alzheimer's Disease6
Network Pharmacology of miR-146a-5p as a Potential Anti-Inflammatory Agent in Preventing Alzheimer's Disease6
Effects of DW2009 on BDNF Levels as a Secondary Analysis of a Randomized Controlled Trial Across Sociodemographic Subgroups6
The Postoperative Effects of Anesthesia Exposure on Cognitive Decline in Older Adults: A Narrative Review6
Environmental Enrichment and Metformin Combination Improves Cognitive Function through BDNF and HPA Axis in Chronically Stressed Rats6
Evidence of Clinical Efficacy and Pharmacological Mechanisms of Resveratrol in the Treatment of Alzheimer’s Disease6
Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease6
Therapeutic Effects of Arctiin on Alzheimer's Disease-like Model in Rats by Reducing Oxidative Stress, Inflammasomes and Fibrosis6
Neuroprotective Agents: Implications for Parkinson's Disease Treatment6
Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis5
White Matter Damage in Alzheimer’s Disease: Contribution of Oligodendrocytes5
Application of Diffusion Tensor Imaging Based on Automatic Fiber Quantification in Alzheimer's Disease5
Exploring Potential of Nano-formulations in the Treatment of Alzheimer’s Disease through Nasal Route5
Prospective Memory in Mobile: Using Smartphone-Based Calendars to Rehabilitate Prospective Memory in Patients with Alzheimer’s Disease5
History of Senile Dementia from the Antiquity to the Beginning of the Modern Age5
Age- and Genotype-Dependent Effects of Chronic Nicotine on Presenilin1/2 Double Knockout Mice: From Behavior to Molecular Pathways5
Complex Processes Underlying the Dynamic Changes of D-serine Levels in AD Brains5
The Immunopathy of Alzheimer’s Disease: Innate or Adaptive?5
Effects of Metformin on Modulating the Expression of Brain-related Genes of APP/PS1 Transgenic Mice based on Single Cell Sequencing5
Identification of MicroRNA Drug Targets for Alzheimer's and Diabetes Mellitus Using Network Medicine5
Clinical and Medication Factors Associated with Cognitive Decline in Dementia: A Healthcare Database Study5
Association Between Cannabis Use and Subjective Cognitive Decline: Findings from the Behavioral Risk Factor Surveillance System (BRFSS)5
Plasma Biomarkers in Neurodegenerative Dementias: Unrevealing the Potential of Serum Oxytocin, BDNF, NPTX1, TREM2, TNF-alpha, IL-1 and Prolactin4
A DTI-Radiomics and Clinical Integration Model for Predicting MCI-to-AD Progression Using Corpus Callosum Features4
Sleep Characteristics in Older Adults with Different Levels of Risk for Dementia: A Cross-sectional Study4
Relation between Cerebrospinal Fluid Catecholamines and Vascular Risk Factors, Thyroid Function and Vitamins in Healthy Individuals and Patients with Neurodegenerative Diseases4
Acknowledgements to Reviewers4
Associations of Multimorbidity with Cerebrospinal Fluid Biomarkers for Neurodegenerative Disorders in Early Parkinson's Disease: A Crosssectional and Longitudinal Study4
Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis4
Prenatal Exposure to the 1944-45 Dutch Famine and Risk for Dementia up to Age 75: An Analysis of Primary Care Data4
An Online Shared Decision-making Intervention for Dementia Prevention: A Parallel-group Randomized Pilot Study4
Multimodal Deep Learning Approaches for Early Detection of Alzheimer’s Disease: A Comprehensive Systematic Review of Image Processing Techniques4
Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima, Peru4
Associations between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer´s Disease, and Type 2 Diabetes Mellitus – A Register-based Study4
Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer’s Disease: A Cross-sectional Study4
Microglial Circadian Rhythms and Neurodegenerative Diseases4
Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer’s Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study4
Post-Hoc Assessment of Cognitive Efficacy in Alzheimer’s Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial4
Antipsychotics in Alzheimer’s Disease: Current Status and Therapeutic Alternatives4
Tauopathy in AD: Therapeutic Potential of MARK-44
MicroRNA Signatures in Alzheimer’s Disease and Normal-Tension Glaucoma: A Comparative Expression Analysis of miR-128 and miR-455-3p4
High Frequency Repetitive Transcranial Magnetic Stimulation Improves Cognitive Performance Parameters in Patients with Alzheimer’s Disease – An Exploratory Pilot Study4
Effect of Transcranial Pulse Stimulation for the Treatment of Alzheimer´s Disease and its Related Symptoms4
Assessment of the Inhibition of AChE and BChE by Carthamus caeruleus Essential Oil and Carline Oxide: Neuroprotective Effects and In Vivo Toxicity Assessment for the Management of Alzheimer’s D4
Effect of Simultaneous Dual-Task Training on Regional Cerebral Blood Flow in Older Adults with Amnestic Mild Cognitive Impairment4
The Role of Microglial Cells and Cytokine Modulation in Alzheimer’s Disease: A Neuroinflammatory Perspective4
0.48213601112366